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Introduction: Chronic polysubstance abuse (SUD) is associated with neurophysiological and neuroanatomical
changes. Neurocognitive impairment tends to affect quality of life, occupational functioning, and the ability to
beneﬁt from therapy. Neurocognitive assessment is thus of importance, but costly and not widely available.
Therefore, in a busy clinical setting, procedures that include readily available measures targeting core cognitive
deﬁcits would be beneﬁcial. This paper investigates the utility of psychometric tests and a questionnaire-based
inventory to assess “hot” and “cold” neurocognitive measures of executive functions (EF) in adults with a sub-
stance use disorder. Hot decision-making processes are associated with emotional, affective, and visceral re-
sponses, while cold executive functions are associated with rational decision-making.
Material and Methods: Subjects with polysubstance abuse (n = 126) and healthy controls (n = 32) were com-
pared on hot (Iowa Gambling Task) and cold (Stroop and the Trail Making Test) measures of EF, in addition to
a questionnaire assessing everyday EF related problems (BRIEF-A; Behavior Rating Inventory of Executive Func-
tion – Adult, self-report version). Information about the substance abuse and social adjustmentwere assessed by
self-report. Logistic regression analyses were applied to assess independent correlates of SUD status and social
adjustment. A multiple linear regression was performed to predict the number of previous treatment attempts.
Results: The psychometric test of hot EF (the Iowa Gambling Task) did not differentiate the patients with
polysubstance abuse from controls, and was not associated with social adjustment. The psychometric tests of
cold EF distinguished somewhat between the groups and were associated with one indicator of social adjust-
ment. The BRIEF-A differentiated between groups on all the clinical scales and was associated with three out of
ﬁve social adjustment indicators (“criminal lifestyle,” “conﬂict with caregiver,” and “stable housing.”).
Conclusions: The BRIEF-A inventory was the most sensitive measure of executive function in patients with sub-
stance use disorder, followed by measures of cold executive function. BRIEF-A should therefore be considered
as an integral part of the clinical routine when assessing patients with SUD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).xecutive function; IGT, Iowa
cutive Function – Adult version;
he computerized Stroop Color
ion Test; DUDIT, The Drug Use
ated Scale of Intelligence; MI,
C, Global Executive Composite.
er.hagen.erga@sus.no
ess@sus.no (S.M. Nesvåg),
old@psych.uib.no
. This is an open access article under1. Introduction
Chronic substance use disorder (SUD) is associatedwith cognitive im-
pairment (Rogers & Robbins, 2001; Vik, Cellucci, Jarchow, & Hedt, 2004;
Yucel, Lubman, Solowij, & Brewer, 2007),with prevalence estimates vary-
ing between 20% and 80% among treatment-seeking abusers of alcohol
and drugs (Bates, Bowden, & Barry, 2002; Copersino et al., 2009).
Although the majority of studies have focused on disorders related
to alcohol use, there is growing evidence indicating similar cognitivethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Garcia, & Verdejo-Garcia, 2011; Grant & Judd, 1976; Vik et al., 2004).
More speciﬁcally, abusers of alcohol, opiates, and stimulants show im-
pairment on tasks assessing different aspects of executive function
(EF), including decision-making and emotional control (Barry & Petry,
2008; Bechara, 2005; Dolan, Bechara, & Nathan, 2008; Verdejo-Garcia
& Bechara, 2010; Verdejo-Garcia, Bechara, Recknor, & Perez-Garcia,
2006). Central symptoms of EF deﬁcits include reduced sensitivity to fu-
ture consequences and impaired decision-making in real-life situations
(Bechara et al., 2001;Grant, Contoreggi, & London, 2000; Schoenbaum&
Shaham, 2008), reduced ability to suppress responses and evaluate con-
sequences, as well as a preference for smaller, instantaneous rewards
over larger, delayed rewards (Cardinal, Winstanley, Robbins, & Everitt,
2004). These deﬁcits commonly present even after 6 months of absti-
nence among polysubstance abusers (Fernandez-Serrano et al., 2011).
EF dysfunction has an impact on quality of life and occupational
functioning, which subsequently affects the course of rehabilitation
therapy and level of community integration among patients with SUD
(Fernandez-Serrano et al., 2011). In a clinical context, patients with
polysubstance abusemay demonstrate intelligence, learning andmem-
ory, language, and attentionwithin the normal range, butmay still show
considerable impairment in emotional function, decision-making, and
social behavior (Bechara, 2005). More speciﬁcally, an association has
been reported between cognitive deﬁcits and low treatment adherence
(Bates, Pawlak, Tonigan, & Buckman, 2006), poor attendance at outpa-
tient therapy sessions (Guthrie & Elliott, 1980), low willingness to
change (Blume & Marlatt, 2009), reduced self-insight (Horner, Harvey,
& Denier, 1999), denial of substance abuse (Rinn, Desai, Rosenblatt, &
Gastfriend, 2002), increased impulsivity, and less abstinence from the
substance of abuse following treatment termination (Aharonovich
et al., 2006). Impaired EF has also been linked tomedical and legal prob-
lems among this patient group (Bechara et al., 2001; Paulus, Tapert, &
Schuckit, 2005).
With neurocognitive deﬁcits recognized as an adverse variable af-
fecting recovery and treatment adherence in SUD patients, a thorough
examination of cognitive functioning, including assessment of EF, is of
paramount importance with regard to formulation of an effective and
clear individual treatment plan, and by this to facilitate improved every-
day coping and functioning in this patient population.
However, neurocognitive assessment services are both expensive
and time consuming. Furthermore, specialized neuropsychological ex-
pertise is usually rare in outpatient settings of SUD treatment. The infre-
quent inclusion of cognitive assessment in clinical practice was
illustrated in a recent study from Norway (Vaskinn & Egeland, 2012),
in spite of being recognized as important in the Norwegian national
guidelines for diagnosing and treating patients with SUD.
To sum up, it is important to develop and apply assessment proto-
cols that both are brief and simple enough to be included in a busy clin-
ical setting, and of importance to real-life situations and treatment.
The need for clinic-friendly neurocognitive measures motivated the
present study to investigate two theoretical EF components, referred to
as “cold” and “hot” EF, in a group of patientswith SUD. Both hot and cold
neurocognitive processes are involved in decision-making (Seguin &
Zelazo, 2005). Hot and cold decision-making processes are rarely inves-
tigated simultaneously. Often studies tend to emphasize the cold path-
way at the expense of the hot pathway (Séguin, Arseneault, & Tremblay,
2007). Previous studies have found, that when compared with controls,
SUD patients exhibit lower scores on performance based measures on
EF and emotion processing measures, and PET studies have established
an association between speciﬁc neural correlates related to cold and hot
executive functions, respectively (Moreno-López et al., 2012).
Related to decision-making, cold EF refers to abilities of importance
when contrasting various alternatives and comparing risk/beneﬁt ratios
(Séguin et al., 2007). Cold cognitive processes are thus involved in a
wide range of abilities, including the ability to keep attention sustained
and focused, to be cognitively ﬂexible, and be able to plan and organizegoal-directed behavior (Burgess, 2000; Stuss, Shallice, Alexander, &
Picton, 1995). These abilities are commonly measured by psychometric
tests such as the Stroop test (MacLeod, 1991) and the Trail Making Test
(Kortte, Horner, &Windham, 2002; Strauss, Allen, Jorgensen, & Cramer,
2005). Neurobiologically, these cognitive processes are shown to be
particularly associated with activation in dorsolateral prefrontal cortex
(Castellanos, Sonuga-Barke, Milham, & Tannock, 2006).
Hot EF involves processes with amore distinct emotional or motiva-
tional salience (Kerr & Zelazo, 2004; Zelazo & Müller, 2002), and have
increasingly been linked to the orbitofrontal cortex (Anderson, Barrash,
Bechara, & Tranel, 2006; Kerr & Zelazo, 2004). Impaired hot EF have a
strong impact on behavioral choices in everyday situations, especially
when stimuli with distinct emotional salience interact with logical or
cold EF (Sonuga-Barke, 2003). The conventional method for assessing
hot EF has been performance-based decision-making tasks with
emotional-laden contingencies (Chan, Shum, Toulopoulou, & Chen,
2008). A key challenge for participants in these tasks is to make long-
term advantageous decisions in uncertain and ambiguous test settings.
The Iowa Gambling Task (IGT) is one such test (Bechara & Damasio,
2002), where impairments has been shown in individuals with alcohol,
cocaine, and opioid use disorders (Bartzokis et al., 2000; Bechara &
Damasio, 2002; Bechara et al., 2001). It has even been argued that the
high proportion of relapse after treatment discharge may be attributed
to impaired hot EF, particularly when exposed to emotional-laden situ-
ations previously associated with substance abuse (Hunt, Barnett, &
Branch, 1971; McKay et al., 1997, 2004).
In addition to performance-based tests, EF can also be investigated
using self-report scales or questionnaires in which participants are
asked about their function in real-life situations. These scales, for exam-
ple the 75-item Behavior Rating Inventory of Executive Functions –
Adult Version (BRIEF-A) (Roth, Isquith, & Gioia, 2005; Roth, Lance,
Isquith, Fischer, & Giancola, 2013), have been shown to have a higher
ecological validity than results obtained in a structured test environ-
ment (Isquith, Roth, & Gioia, 2013; Roth et al., 2005). Furthermore,
they clearly have time and cost advantages over laboratory-based per-
formance measures.
With an aim to document EF impairment in patientswith SUDof im-
portance to real-life social adjustment and treatment, the present study
included a set of tests of the theoretical cold and hot components of EF,
including both psychometric tests and a questionnaire-based inventory
(BRIEF-A). We investigated their efﬁciency in characterizing the SUD
patients when compared to a control group.
2. Material and methods
2.1. Design
The study was part of a prospective, longitudinal cohort study of an
SUD patient sample who started a new treatment sequence in the Sta-
vanger University Hospital catchment area. This paper presents data
collected from SUD patients admitted to both outpatient and residential
treatment facilities. To minimize contamination from drug withdrawal
and acute neurotoxic effects from psychoactive substance, participants
were tested after 2 weeks of abstinence (Miller, 1985). The project
was approved by the Regional Ethical Committee (REK 2011/1877).
2.2. Participants and procedures
One hundred and ﬁfty participants were recruited from outpatient
and residential treatment facilities within the region, across 10 enroll-
ment sites. Patients were recruited between March 2012 and May
2013. Consecutive enrollmentwas continued until the required number
of participants was recruited. The SUD group included patients
reporting use of more than one drug at a single occasion or a history
of having injected or abused multiple drugs, based on responses to the
Alcohol Use Disorders Identiﬁcation Test (AUDIT) (Bohn, Babor, &
Table 1
Substance use and treatment history.
SUD patients (n = 126)
Age at initial use 13.1 (2.0)
Years of drug abuse 15.2 (8.0)
AUDIT total score 14.8 (10.5)
DUDIT total score 35.9 (8.5)
Have injected? n 82 (65.1%)
Treatment attempts, n
0 44 (34.9%)
1 36 (28.6%)
2 19 (15.1%)
3 9 (7.1%)
4 7 (5.6%)
≥5 11 (6.5%)
All data are mean (SD) unless otherwise indicated.
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(Voluse et al., 2012). Scores on these tests are summarized in Table 1.
Five patients were excluded due to not having a substance-related ad-
diction. One patient was excluded due to only using cannabis, one due
to only using opioids, and 14 due to only using alcohol. We did not ex-
clude patients with comorbid psychiatric conditions. The control
group (n=38)was a convenience sample recruited using posters at so-
cial welfare and primary care ofﬁces. Controls and patients were offered
compensation of NOK 400 for baseline testing. Nine patients (seven 17-
years of age, two 16-years of age) were excluded due to age. The ﬁnal
group consisted of n = 126 SUD patients and n = 32 controls. Baseline
demographic variables for the control vs the SUD groups are summa-
rized in Table 2.
2.3. Inclusion procedure
Tobe eligible for admission to the study, patients needed to: a) sign a
written informed consent to participate; b) embark on a new treatment
sequence within the substance abuse treatment service; and c) be at
least 18 years of age. Patients also had to be enrolled in the program
to which they were admitted for at least 2 weeks, and abstinence was
veriﬁed through self-report, for both inpatients and outpatients. In
one of the ﬁrst treatment sessions (1–3), patients were given an infor-
mation sheet with a short project description.
2.4. Measures
Cold EF is commonly measured with the computerized Stroop test
(Stroop CW) (Golden & Freshwater, 1978). Stroop is an assessment of
attention, interference, and inhibition of dominant responses
(MacLeod, 1991). Longer reaction times and number of errors indicate
impaired performance. Another measure of cold EF is the Trail Making
Test (TMT) (Kortte et al., 2002; Strauss et al., 2005). TMT provides
data on visual–conceptual and visual–motor tracking and set shifting.Table 2
Demographic variables for the control and SUD groups.
Controls (n = 32) SUD patients (n = 126) P-value
Male, n 13 (40.6) 85 (67.5) 0.005a
Age 33.7 (13.0) 28.5 (8.0) 0.064b
Years of education 14.5 (3.1) 11.7 (1.8) 0.001c
Native Norwegian, n 32 (100) 120 (95.2) 1.000d
Permanent home, n 32 (100) 71 (56.3) 0.001a
Stable income, n 29 (90.6) 87 (69.0) 0.014a
Criminal lifestyle, n 0 (0.0) 32 (25.4) 0.001a
Years of work experience 11.6 (9.4) 5.8 (5.9) 0.001b
WASI Total IQ 106.2 (13.2) 98.6 (11.6) 0.002c
a Pearson's χ2.
b Mann–Whitney U Test.
c Independent samples t-test.
d Fisher's exact test. All data are mean (SD), unless otherwise speciﬁed.There are two test subsections: Trail Making-A (TMT-A), in which the
targets are all numbers, and Trail Making-B (TMT-B), in which the sub-
ject alternates between numbers and letters. TMT-B is sensitive to cog-
nitive ﬂexibility, sequencing, motor speed, and response inhibition.
Longer time to ﬁnish indicates impairment.
Hot EF has predominantly been examined using the Iowa Gambling
Task (IGT) (Bechara, Damasio, Damasio, & Anderson, 1994). The key
challenge in the IGT is to make advantageous long-term decisions in
conditions of uncertainty. For this test, subjects are given $2,000 to
start and their task is to maximize proﬁt across 100 trials by choosing
cards from one of four decks. After 10 selections from decks A and B,
the subject will have earned a net loss of $250, whereas decks C and D
result in a net gain of $250. Consequently, decks A and B are the
“risky” decks. The hot element of IGT varies throughout the testing pro-
cedure. It is assumed that the perception of riskwithin the IGT increases
across trials, as subjects gain experiencewith thewin/loss contingencies
in the various decks (i.e. later trails have stronger emotional, or risky, as-
sociations) (Brand, Recknor, Grabenhorst, & Bechara, 2007).
The BRIEF-A is a self-report questionnaire composed of nine sub-
scales and three composite scores. The Behavioral Regulations Index
(BR-index) consists of the subscales inhibit, shift, self-monitor and
emotional-control. The subscales initiate, plan/organize, workingmem-
ory, organization of materials, and task-monitor comprise theMetacog-
nition Index (MI). The BRI and MI can be combined to produce the
overall global executive composite (GEC). Validity scales were exam-
ined, and two control and 10 SUD participants' proﬁles were excluded
due to invalid response styles.
Speciﬁc information on substance abuse was based on self-reported
responses on the AUDIT (Bohn et al., 1995) and theDUDIT (Voluse et al.,
2012). The Wechsler Abbreviated Scale of Intelligence (WASI) was in-
cluded as a control variable, because there was a signiﬁcant difference
between controls and SUD patients on the univariate analysis, and to
ensure that EF deﬁcits could not be attributed to general abilities.
After ensuring validity of WASIs' index levels, WASI full scale score
was used in further analysis. Experienced and trained psychometric
staff administered all tests. An interview based on items from the pre-
liminary version of the National Quality Register for Substance Abuse
Treatment was used to collect demographics, type of addiction, initial
age at use, treatment and work history, educational, and vocational
data. Social adjustment scores were obtained based on a yes/no re-
sponses from the same quality register, and included the following cat-
egories: permanent housing, criminal lifestyle, conﬂict with caregivers,
friends outside the drug environment, and stable income.
2.5. Statistical analyses
All statistical analyses were performed using IBM SPSS software (v.
22 for Windows). P-values b .05 were considered statistically signiﬁ-
cant. Group differences were analyzed using Student's t-test, Mann–
Whitney tests, Pearson's χ2 test and Fisher's exact probability test (for
2 × 2 tables) as appropriate. Normality was controlled for using histo-
grams and Kolmogorov–Smirnov test, and Levene's test was used to se-
lect the appropriate p-values based onwhether the assumption of equal
variances within groups was met. Effect sizes are reported as Cohen's d
(standardizedmeandifferences), forwhich0.3 is considered a small, 0.5
a medium, and ≥0.8 a large effect (Cohen, 1992).
Binary logistic regression analyses (enter method) were applied to
assess independent correlates of SUD status and categorical variables in-
dicating social adjustment. In these analyses, control variables (age, sex,
years of education, andWASI Total IQ), and raw scores from the cold EF,
hot EF, and BRIEF-A BRI andMI, were sequentially entered to the analy-
ses. A multiple linear regression was performed to predict the number
of previous treatment attempts. As a quantiﬁed measure of goodness-
of-ﬁt, Nagelkerke's R2 was estimated and reported. Due to the signiﬁ-
cant difference in WASI total IQ between controls and patients, WASI
total IQ was included in a control variable in these analyses.
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3.1. Demographics, substance abuse, and treatment history
A summary of the demographic variables is presented in Table 2.
There were signiﬁcant differences in gender (40.6 % vs 67.5 % males in
control and SUD group) and years of education (14.5 ± 3.1 vs 11.7 ±
1.8) between the controls and SUD groups. Themean years ofwork expe-
rience was 11.6 (±9.4) in controls, compared to 5.8 (±5.9) in the SUD
group. There was also a moderate but signiﬁcant group difference in
WASI Total IQ score in favor of the control group (d=0.611, p=0.002).
A summary of substance use and treatment history for SUD patients
is presented in Table 1. The mean debut age of drug use was 13.1
(±2.0), and the mean years of drug abuse was 15.2 (±8.0) years. The
mean AUDIT score was 14.8 (±10.5), and mean DUDIT score was 35.9
(±8.5). The majority (65.1 %) of the patients had tried injection as a
form of drug administration. For a detailed overview of the treatment
history of the patients, please refer to Table 1.
3.2. SUD vs control: executive functions
A summary of performance on cognitive tests for controls and SUD
patients is presented in Table 3. The control group signiﬁcantly
outperformed the SUD group on the Stroop CWvariables word reading,
color naming and color/word naming, with moderate effect sizes. There
was no group difference on the Stroop Interference task. There was a
signiﬁcant group difference on TMT part A (d= 0.452, p= 0.028) but
not TMT part B (d=0.086, p=0.658). The SUD groupwas slightly bet-
ter on IGT but this did not reach statistical signiﬁcance for either the
total score or the learning curve IGT variables. Therewas a signiﬁcant in-
crease in standard T-scores between SUD patients and controls on all
BRIEF-A subtests.
The results of all the regression analyses are summarized in Fig. 1.
Overall, SUD status was signiﬁcantly associated with control variables
(χ2 = 53.53, p b 0.001; R2 = 0.336), and the BRIEF-A BRI and MI
(χ2 = 15.90, p b 0.001; R2 = 0.110). SUD status was not associatedTable 3
Performance on cognitive tests for control and SUD groups.
Controls
(n = 32)
SUD patients
(n = 126)
P- value# Effect
size⁎
Stroop
Word reading 92.3 (13.9) 85.2 (12.8) 0.007 0.531
Color naming 69.0 (13.8) 62.3 (10.6) 0.013 0.545
Color/Word naming 43.8 (12.4) 38.9 (9.6) 0.019 0.441
Interference 4.3 (8.6) 5.9 (14.0) 0.524 0.137
Trail Making Test
Part A 26.1 (9.2) 31.8 (12.3) 0.016 0.524
Part B 62.9 (32.2) 73.1 (43.6) 0.157 0.267
Iowa Gambling Task
Total NET raw score 0.4 (18.6) 4.9 (26.0) 0.272 0.199
BRIEF-A§
Inhibit 51.1 (7.9) 64.4 (11.7) 0.001 1.332
Shift 50.9 (9.5) 62.2 (10.4) 0.001 1.134
Emotional control 40.3 (8.0) 59.0 (9.2) 0.001 2.169
Self-monitoring 50.6 (10.3) 59.8 (11.3) 0.001 0.857
BRI 50.3 (10.7) 63.4 (9.8) 0.001 1.276
Initiate 51.0 (10.7) 66.0 (11.2) 0.001 1.369
Working memory 53.7 (11.6) 65.2 (11.3) 0.001 1.004
Plan/Organize 53.2 (10.5) 63.0 (10.4) 0.001 0.937
Task monitoring 54.2 (10.6) 60.9 (11.2) 0.004 0.614
Organization of materials 50.1 (8.7) 55.2 (10.9) 0.019 0.517
Metacognition Index 52.8 (10.7) 64.0 (10.4) 0.001 1.061
BRI = Behavioral Regulation Index; All data are mean (SD), unless otherwise indicated.
The analysis on BRIEF-A shown above is therefore based on a sample of n = 30 control
and n = 116 SUD participants.
# Student's t-test.
⁎ Effect size reported as Cohen's d.
§ Due to invalid BRIEF-A protocols, n = 2 control and n = 10 SUD participants were
excluded from the analyses.with hot (χ2 = 1.49, p = 0.223; R2 = .010) or cold EF measures, al-
though the association is close to statistical signiﬁcant for cold EF
(χ2 = 12.23, p= 0.057; R2 = 0.088).
3.3. Social adjustment
Overall, social adjustment variables were not linked to control vari-
ables; except that higher education was signiﬁcantly related to “stabile
income” (B= 0.345, p=0.005) and “friends outside the drug environ-
ment” (B=0.464, p=0.008). Increased agewas also signiﬁcantly relat-
ed to “stabile income” (B = 0.051, p = 0.048). Overall, there were no
signiﬁcant associations between social adjustment and hot or cold cog-
nitive tests. However, increased T-scores on BRIEF-A BRI was signiﬁ-
cantly related to adverse outcomes on “stabile income” (B = −0.77,
p = 0.007), “conﬂict with caregiver,” (B = 0.09, p =0.007), “stabile
housing” (B =−0.83, p= 0.002).
A multiple linear regression analysis (enter method) predicting the
number of previous treatment attempts was performed using the
same independent variables. The overall model was signiﬁcant, and
more treatment attempts were predicted by increased score on Stroop
interference (B = 0.09, p N 0.001) and TMT part A (B = 0.04,
p N 0.038). The number of previous treatment attempts was also nega-
tively related to a reduced BRIEF MI score (B =−0.07, p = 0.014).
4. Discussion
Overall, the regression analyses in the present study found that the
BRIEF-A inventory was a signiﬁcant predictor of substance use status.
The MI of BRIEF-A also predicted social adjustment scores, and the MI
predicted number of previous treatment sessions within the SUD
group. The contribution of the selected performance-based measures
was sparse, although group comparisons showed that the control-
group was faster on the three conditions from the Stroop test and the
Trail Making Test part A.
4.1. Group membership
The measures of cold EF distinguished between patients with SUD
and controls. The controlswere faster on the Stroop reading andnaming
tasks, and the Trail Making Test part A. These ﬁndings are in line with
previous research, where SUD patients often exhibit impairments in in-
hibitory control, set shifting and reduced ability to suppress responses
(Cardinal et al., 2004). This difference in cold EF is even evident in ado-
lescents at risk for developing SUDwhen compared to peers (McNamee
et al., 2008).
The SUD group performed slightly (but not signiﬁcantly) better on
the hot EF, measured by the IGT total score. A similar paradoxical effect
on IGT performance and education has been documented in a previous
study, but existing studies vary in their ﬁndings. Functional impair-
ments based on IGT have been found in individuals with alcohol, co-
caine, and opioid use disorders, relative to healthy controls (Bartzokis
et al., 2000; Bechara & Damasio, 2002; Bechara et al., 2001). However,
ﬁndings are not conclusive, and a number of studies have shown that
groups of healthy controls do not learn to successfully select cards
from the advantageous decks, and also showing high variance in antic-
ipatory electro-dermal responses (Dunn, Dalgleish, & Lawrence, 2006).
The contradicting ﬁndings from some studies, where controls perform
poorly on IGT while not showing any deﬁciencies in real-life decision
making, makes it unclear whether IGT performance have predictive
value on real life functioning.
The demographic variables age, gender, education andWASI IQ pre-
dicted group membership better than the hot and cold EF measures.
WASI provides a brief assessment of general intellectual abilities
(Canivez, Konold, Collins, &Wilson, 2009), and these results are not sur-
prising, given the impact of the G factor; IQ scores correlate with aca-
demic performance and performance in other areas of life (Kline,
Fig. 1. Independent and dependent variables and results of the regression analyses. Level of prediction expressed as Nagelkerke's R2.
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ing ability that is useful in solving a wide variety of problems in life
(Kline, 2013a).
Responses on BRIEF-A was signiﬁcantly elevated on all the nine scales
for SUD patients compared to the controls. Previous studies have found
similar results, where current polydrug users report signiﬁcantly
more executive dysfunction on BRIEF-A, compared to non-users
(Hadjiefthyvoulou, Fisk, Montgomery, & Bridges, 2012). Several studies
have supported the validity of the BRIEF scales and other rating scales in
assessing every-day executive functioning (Isquith et al., 2013). Moreover,
there are established associations between BRIEF scores and correspond-
ing neural substrates (P. Anderson, 2002), ecological validity with regard
to predicting both every-day functioning (Isquith et al., 2013), and aca-
demic performance (Waber, Gerber, Turcios, Wagner, & Forbes, 2006).
Similar to our ﬁndings, it has proven difﬁcult to establish associa-
tions between neuropsychological performance tests and rating scales
of EF, and this has raised questions whether the two assessment strate-
gies address different cognitive functions or different applications of
cognitive skills (Isquith et al., 2013; McAuley, Chen, Goos, Schachar, &
Crosbie, 2010). Isquith et al. (2013) offers a possible frame of explana-
tion where neuropsychological performance tests are hypothesized toassess cold aspects of EF, and rating scales address a hot emotional as-
pect of EF. With regard to the BRIEF-A, this hypothesis draws support
from research that have applied conﬁrmatory factor analysis of the
BRIEF-A scales, and detected a distinct emotional regulatory factor,
consisting of the Emotional Control and Shift scales (Gioia, Isquith,
Retzlaff, & Espy, 2002). Previous studies have speculated that the BR
index is in fact a measure of hot EF, in contrast to the less emotional
items constituting the remaining scales (Egeland & Fallmyr, 2010).
This distinct hot factor in BRIEF has been replicated in several studies
(McCandless & O' Laughlin, 2007; Peters, Algina, Smith, & Daunic,
2012). On the other hand, a recent study, (Skogli, Egeland, Andersen,
Hovik, & Øie, 2014) onhot and cold EF inADHD found no correlation be-
tween any of the BRIEF scales and performance based measures of hot
performance EF. The correlation matrix displayed marginally higher
correlation between cold EF tests and cold BRIEF scales than with the
hot BRIEF scales. Overall cold BRIEF scales reachedmoderate correlation
with cold EF tests. To our knowledge themajority of these ﬁndings have
been based on studies of with attention deﬁcit hyperactivity disorder,
andwe have not succeeded in ﬁnding previous studies investigating as-
sociations between neuropsychological performance tests and rating
scales of EF adult SUD samples.
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BRIEF-Awas associatedwith SUD aswell as some indicators of social
adjustment in SUD patients. Even when controlling for signiﬁcant de-
mographic variables, the BRI in BRIEF-Awas associated with several do-
mains of social adjustment, where increased scores on the BRI of the
BRIEF-A were related to both substance abuse and lower social func-
tioning. The BRI consists of four subscales crucial for real-life adaptive
social behavior, which offers a plausible explanation for our ﬁndings.
The Inhibit scale assesses the ability to assert impulse control (go/no-
go), and towhat extent one is able to inhibit, stop or adjust one's behav-
ior when called for by the circumstances. The Shift scale assesses one's
ability to ﬂexibly change from alternating situations, tasks or aspects
of challenges. The Emotional control scale assesses one's ability to regu-
late the expression of emotional responses, while the Self-Monitor scale
assesses interpersonal awareness and to which extent one understands
how one's behavior affects others (Roth et al., 2005). The BRIEF-A ques-
tionnaire measure participant's subjective evaluation about their func-
tion in real-life situations, and our ﬁndings suggest that the BRIEF-A
have a higher ecological validity than results obtained on performance
based tests.
We did not ﬁnd any association between performance-based assess-
ment of hot or cold EF and SUD, or social adjustment in the SUD group.
There is a scarceness of literature detailing the link between perfor-
mance basedmeasures of hot and cold EF in SUD, and their relationwith
social adjustment. However, regarding neurocognitive predictors of so-
cial adjustment, studies of patients with closed brain injury indicates
that impairments in overall social adjustment (occupational status, lei-
sure activities, social contacts and family life), are closely linked to the
severity of the damage and subsequent cognitive sequela (Oddy,
Coughlan, Tyerman, & Jenkins, 1985).
Our ﬁndings suggest that typical and commonly used
neurocognitive performance based assessments might render a false
negative outcome in an initial evaluation, while a questionnaire-based
self-evaluation might predict impaired social adjustment associated
with substance abuse.
The lack of relationships between self-rating measures and perfor-
mance basedmeasures of EF could imply that they aremeasuring differ-
ent aspects of executive functions, and some suggest that performance
measures are particularly sensitive to components of executive func-
tions in isolation, while rating scales assess application of those skills,
(Isquith et al., 2013). It has been argued that traditional neuropsycho-
logical tests artiﬁcially fractionate an integrated functional network
(Burgess, 1997), and that the operationalization and types of methods
used to measure EF impacts the conclusions and interpretations we
can make. Our results indicate that IGT and BRIEF-A BRI assess two dif-
ferent cognitive constructs. IGT is presumably sensitive to subtle, un-
conscious perceptions of somatosensory feedback or “hunches” to
guide decision-making, whereas the BR index from BRIEF-A captures
the responder's own view of his or her ability to maintain appropriate
control of their own behavior and emotional responses (Roth et al.,
2005). This is supported by recent ﬁndings showing only minimal corre-
lations between the two types of measures (Toplak, West, & Stanovich,
2013), providing further support for the hypothesis that there are sepa-
rate EF pathwaysmeasured by IGT versus BRIEF-A (Sonuga-Barke, 2003).
4.3. Strengths and limitations
The SUDparticipantswere recruited from ten different treatment fa-
cilities within the Stavanger University Hospital region. The patients
were asked by their counselor whether they wished to participate. We
have no data describing the patients that declined research participa-
tion. A Norwegian study found a threefold increase in the rate of disabil-
ity pensions among patients who chose not to participate in the
Hordaland Health Study (Knudsen, Hotopf, Skogen, Øverland, &
Mykletun, 2010). Furthermore, nonparticipants were characterized bypoorer lifestyle habits including smoking and drug and alcohol abuse
(Korkeila et al., 2001; Shahar, Folsom, Jackson, & The Atherosclerosis
Risk in Communities Study, I, 1996) and had lower scores on indicators
of somatic andmental health (Drivsholm et al., 2006). It is therefore likely
that the patients that declined research participation would have in-
creased, rather than decreased, the group differences reported here.
The SUD and control groups were different on a number of demo-
graphic variables. Age, sex, education, and IQ were included as covari-
ates in the statistical analyses to adjust for this limitation somewhat.
The signiﬁcant difference in education between the SUD and control
groupwas challenging to avoid. It was almost impossible to ﬁnd control
participants with fewer than 10 years of education that did not have a
substance abuse problem.
This research ﬁeld faces a number of interpretive challenges as to the
etiology of cognitive deﬁcits associated with substance abuse. Psychiatric
comorbidity, medical risk factors (e.g. head trauma, HIV, malnutrition,
overdose), genetic predispositions, and premorbid vulnerability (e.g. ge-
netic, psychosocial, and environmental) may all play signiﬁcant causal
roles leading to the current neuropsychological proﬁle. Several psychiatric
diagnoses are characterized by changes in EF, and psychiatric functioning
was assessedwith self-report, and not supplementedwith observer-rated
scales. To ensure validity and reliability in assessment of psychopatholog-
ical symptoms, it is recommended that both subjective-, and observer rat-
ing are employed (Möller, 2009). Hence, it is possible that our ﬁndings
could be impacted by comorbid psychiatric symptoms.
Furthermore, although there is marked evidence of an association
between different aspects of SUD and cognitive impairment, the direct
versus indirect roles of the various substances are not clear. Theoretical-
ly, a number of cognitive deﬁcits could be viewed as antecedents to the
onset of SUD, especially those involving EF connected to decision-
making and impulsivity (Nigg, Blaskey, Huang-Pollock, & Rappley,
2002; Nigg et al., 2006).5. Conclusions
The BRIEF-A inventory was the most sensitive measure of EF in pa-
tients with substance use disorder, followed by measures of cold EF.
Evaluation with BRIEF-A should thus be considered as an integral part
of the clinical routine when dealing with assessment of patients with
SUD. Assessment of EFmay contribute to the scientiﬁc and clinical effort
of understanding the cognitive and behavioral aspects of SUD, and could
prove vital in tailoring SUD treatment programs, particularly consider-
ing the high dropout numbers at early treatment stages. However, it is
well known that neurocognitive assessment services are scarce, costly,
and generally unavailable to SUDpatients. Hence, it is crucial to develop,
evaluate, and apply testing procedures that could bemademore readily
available in busy clinical settings and that could also be administered by
a broader array of professions. Our data indicate a promising potential
for inventory-based EF assessment in SUD patients as measured by
BRIEF-A. Self-report measures of EF can be valuable, cost-effective, and
accurate at an initial clinical evaluation, providing important comple-
mentary measures to performance based tests.Role of the funding source
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